|
1
|
Lu TX and Rothenberg ME: Diagnostic,
functional, and therapeutic roles of microRNA in allergic diseases.
J Allergy Clin Immunol. 132:3–13; quiz 14. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Galli SJ and Tsai M: Mast cells in allergy
and infection: versatile effector and regulatory cells in innate
and adaptive immunity. Eur J Immunol. 40:1843–1851. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mekori YA and Metcalfe DD: Mast cells in
innate immunity. Immunol Rev. 173:131–140. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Brown JM, Wilson TM and Metcalfe DD: The
mast cell and allergic diseases: role in pathogenesis and
implications for therapy. Clin Exp Allergy. 38:4–18. 2008.
|
|
5
|
Huang J, Zhang T, Han S, Cao J, Chen Q and
Wang S: The inhibitory effect of piperine from Fructus piperis
extract on the degranulation of RBL-2H3 cells. Fitoterapia.
99:218–226. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sumpter TL, Ho CH, Pleet AR, Tkacheva OA,
Shufesky WJ, Rojas-Canales DM, Morelli AE and Larregina AT:
Autocrine hemokinin-1 functions as an endogenous adjuvant for
IgE-mediated mast cell inflammatory responses. J Allergy Clin
Immunol. 135:1019–1030. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bradding P, Roberts JA, Britten KM,
Montefort S, Djukanovic R, Mueller R, Heusser CH, Howarth PH and
Holgate ST: Interleukin-4, -5, and -6 and tumor necrosis
factor-alpha in normal and asthmatic airways: Evidence for the
human mast cell as a source of these cytokines. Am J Respir Cell
Mol Biol. 10:471–480. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Molina-Holgado E and Molina-Holgado F:
Mending the broken brain: Neuroimmune interactions in neurogenesis.
J Neurochem. 114:1277–1290. 2010.PubMed/NCBI
|
|
9
|
Yokoyama A, Kohno N, Sakai K, Kondo K,
Hirasawa Y and Hiwada K: Circulating levels of soluble
interleukin-6 receptor in patients with bronchial asthma. Am J
Respir Crit Care Med. 156:1688–1691. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yanagida M, Fukamachi H, Ohgami K, Kuwaki
T, Ishii H, Uzumaki H, Amano K, Tokiwa T, Mitsui H, Saito H, et al:
Effects of T-helper 2-type cytokines, interleukin-3 (IL-3), IL-4,
IL-5, and IL-6 on the survival of cultured human mast cells. Blood.
86:3705–3714. 1995.PubMed/NCBI
|
|
11
|
Rebane A and Akdis CA: MicroRNAs:
Essential players in the regulation of inflammation. J Allergy Clin
Immunol. 132:15–26. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mayoral RJ, Pipkin ME, Pachkov M, van
Nimwegen E, Rao A and Monticelli S: MicroRNA-221-222 regulate the
cell cycle in mast cells. J Immunol. 182:433–445. 2009. View Article : Google Scholar :
|
|
13
|
Qin HB, Xu B, Mei JJ, Li D, Liu JJ, Zhao
DY and Liu F: Inhibition of miRNA-221 suppresses the airway
inflammation in asthma. Inflammation. 35:1595–1599. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen CZ, Li L, Lodish HF and Bartel DP:
MicroRNAs modulate hematopoietic lineage differentiation. Science.
303:83–86. 2004. View Article : Google Scholar
|
|
15
|
Lim LP, Glasner ME, Yekta S, Burge CB and
Bartel DP: Vertebrate microRNA genes. Science. 299:15402003.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Haneklaus M, Gerlic M, O'Neill LA and
Masters SL: miR-223: infection, inflammation and cancer. J Intern
Med. 274:215–226. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Johnnidis JB, Harris MH, Wheeler RT,
Stehling-Sun S, Lam MH, Kirak O, Brummelkamp TR, Fleming MD and
Camargo FD: Regulation of progenitor cell proliferation and
granulocyte function by microRNA-223. Nature. 451:1125–1129. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen Q, Wang H, Liu Y, Song Y, Lai L, Han
Q, Cao X and Wang Q: Inducible microRNA-223 down-regulation
promotes TLR-triggered IL-6 and IL-1β production in macrophages by
targeting STAT3. PLoS One. 7:e429712012. View Article : Google Scholar
|
|
19
|
Zhou Y, Yang J, Deng H, Xu H, Zhang J, Jin
W, Gao H, Liu F and Zhao D: Respiratory syncytial virus infection
modulates interleukin 8 production in respiratory epithelial cells
through a transcription factor activator protein 1 signaling
pathway. Mol Med Rep. 10:1443–1447. 2014.PubMed/NCBI
|
|
20
|
Akira S and Kishimoto T: IL-6 and NF-IL6
in acute-phase response and viral infection. Immunol Rev.
127:25–50. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Taïbi F, Metzinger-Le Meuth V, Massy ZA
and Metzinger L: miR-223: an inflammatory oncomiR enters the
cardiovascular field. Biochim Biophys Acta. 1842:1001–1009. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim MS, Rådinger M and Gilfillan AM: The
multiple roles of phosphoinositide 3-kinase in mast cell biology.
Trends Immunol. 29:493–501. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim MS, Kuehn HS, Metcalfe DD and
Gilfillan AM: Activation and function of the mTORC1 pathway in mast
cells. J Immunol. 180:4586–4595. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Okayama Y, Tkaczyk C, Metcalfe DD and
Gilfillan AM: Comparison of Fc epsilon RI- and Fc gamma RI-mediated
degranulation and TNF-alpha synthesis in human mast cells:
Selective utilization of phosphatidylinositol-3-kinase for Fc gamma
RI-induced degranulation. Eur J Immunol. 33:1450–1459. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tkaczyk C, Beaven MA, Brachman SM,
Metcalfe DD and Gilfillan AM: The phospholipase C gamma 1-dependent
pathway of Fc epsilon RI-mediated mast cell activation is regulated
independently of phosphatidylinositol 3-kinase. J Biol Chem.
278:48474–48484. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fazi F, Racanicchi S, Zardo G, Starnes LM,
Mancini M, Travaglini L, Diverio D, Ammatuna E, Cimino G, Lo-Coco
F, et al: Epigenetic silencing of the myelopoiesis regulator
microRNA-223 by the AML1/ETO oncoprotein. Cancer Cell. 12:457–466.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chacón-Salinas R, Limón-Flores AY,
Chávez-Blanco AD, Gonzalez-Estrada A and Ullrich SE: Mast
cell-derived IL-10 suppresses germinal center formation by
affecting T follicular helper cell function. J Immunol. 186:25–31.
2011. View Article : Google Scholar :
|
|
28
|
Biethahn K, Orinska Z, Vigorito E,
Goyeneche-Patino DA, Mirghomizadeh F, Föger N and Bulfone-Paus S:
miRNA-155 controls mast cell activation by regulating the PI3Kγ
pathway and anaphylaxis in a mouse model. Allergy. 69:752–762.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Romo-Lozano Y, Hernández-Hernández F and
Salinas E: Sporothrix schenckii yeasts induce ERK pathway
activation and secretion of IL-6 and TNF-α in rat mast cells, but
no degranulation. Med Mycol. 52:862–868. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
O'Neill LA, Sheedy FJ and McCoy CE:
MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat
Rev Immunol. 11:163–175. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang HJ, Huang YL, Shih YY, Wu HY, Peng CT
and Lo WY: MicroRNA-146a decreases high glucose/thrombin-induced
endothelial inflammation by inhibiting NAPDH oxidase 4 expression.
Mediators Inflamm. 2014:3795372014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Malmhall C, Alawieh S, Lu Y, Sjöstrand M,
Bossios A, Eldh M and Rådinger M: MicroRNA-155 is essential for
TH2-mediated allergen-induced eosinophilic inflammation
in the lung. J Allergy Clin Immunol. 133:1429–1438.
1438.e1421–1427. 2014. View Article : Google Scholar
|
|
33
|
Wu L, Li H, Jia CY, Cheng W, Yu M, Peng M,
Zhu Y, Zhao Q, Dong YW, Shao K, et al: MicroRNA-223 regulates FOXO1
expression and cell proliferation. FEBS Lett. 586:1038–1043. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang Q, Zhao DY, Xu H, Zhou H, Yang QY,
Liu F and Zhou GP: Down-regulation of microRNA-223 promotes
degranulation via the PI3K/Akt pathway by targeting IGF-1R in mast
cells. PLoS One. 10:e01235752015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bauernfeind F, Rieger A, Schildberg FA,
Knolle PA, Schmid-Burgk JL and Hornung V: NLRP3 inflammasome
activity is negatively controlled by miR-223. J Immunol.
189:4175–4181. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li J, Guo Y, Liang X, Sun M, Wang G, De W
and Wu W: MicroRNA-223 functions as an oncogene in human gastric
cancer by targeting FBXW7/hCdc4. J Cancer Res Clin Oncol.
138:763–774. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Josse C, Bouznad N, Geurts P, Irrthum A,
Huynh-Thu VA, Servais L, Hego A, Delvenne P, Bours V and Oury C:
Identification of a microRNA landscape targeting the PI3K/Akt
signaling pathway in inflammation-induced colorectal
carcinogenesis. Am J Physiol Gastrointest Liver Physiol.
306:G229–G243. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhao Y, Zhang C, Huang Y, Yu Y, Li R, Li
M, Liu N, Liu P and Qiao J: Up-regulated expression of WNT5a
increases inflammation and oxidative stress via PI3K/AKT/NF-κB
signaling in the granulosa cells of PCOS patients. J Clin
Endocrinol Metab. 100:201–211. 2014. View Article : Google Scholar
|
|
40
|
Hu G, Huang X, Zhang K, Jiang H and Hu X:
Anti-inflammatory effect of B-type natriuretic peptide
postconditioning during myocardial ischemia-reperfusion:
involvement of PI3K/Akt signaling pathway. Inflammation.
37:1669–1674. 2014. View Article : Google Scholar : PubMed/NCBI
|
